Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis

BACKGROUND: Currently, there is no evidence on the combination of lamivudine and thymosin alpha-1 on chronic hepatitis B patients. The aim of this study was to compare the effect of lamivudine monotherapy with that of lamivudine and thymosin alpha-1 combination therapy for the treatment of hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuan-Yuan, Chen, En-Qiang, Yang, Jin, Duan, Yu-Rong, Tang, Hong
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693103/
https://www.ncbi.nlm.nih.gov/pubmed/19467157
http://dx.doi.org/10.1186/1743-422X-6-63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693103/
https://www.ncbi.nlm.nih.gov/pubmed/19467157
http://dx.doi.org/10.1186/1743-422X-6-63

Ejemplares similares